PA
IBB icon

PFG Advisors’s iShares Biotechnology ETF IBB Stock Holding History

PFG Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$498K Sell
2,617
-192
-7% -$33K 0.03% 534
2026
Q1 		$474K Buy
2,809
+616
+28% +$105K 0.02% 556
2025
Q4 		$370K Sell
2,193
-3,359
-61% -$546K 0.02% 594
2025
Q3 		$802K Buy
+5,552
New +$758K 0.03% 435
2025
Q2 		– Sell
-4,393
Closed -$562K – 674
2025
Q1 		$562K Sell
4,393
-8
-0.2% -$1.08K 0.03% 441
2024
Q4 		$582K Sell
4,401
-145
-3% -$20.4K 0.04% 428
2024
Q3 		$662K Buy
4,546
+4
+0.1% +$579 0.04% 378
2024
Q2 		$623K Sell
4,542
-113
-2% -$15.1K 0.04% 384
2024
Q1 		$639K Buy
4,655
+173
+4% +$23.6K 0.05% 350
2023
Q4 		$609K Sell
4,482
-144
-3% -$17.6K 0.05% 334
2023
Q3 		$566K Sell
4,626
-601
-11% -$76.4K 0.05% 336
2023
Q2 		$664K Sell
5,227
-1,041
-17% -$135K 0.05% 356
2023
Q1 		$810K Sell
6,268
-531
-8% -$69.5K 0.07% 309
2022
Q4 		$893K Buy
6,799
+938
+16% +$121K 0.09% 269
2022
Q3 		$686K Buy
+5,861
New +$728K 0.08% 280
2022
Q1 		– Sell
-7,186
Closed -$1.1M – 454
2021
Q4 		$1.1M Sell
7,186
-764
-10% -$118K 0.11% 234
2021
Q3 		$1.28M Sell
7,950
-1,153
-13% -$194K 0.14% 198
2021
Q2 		$1.49M Sell
9,103
-314
-3% -$48.4K 0.17% 171
2021
Q1 		$1.42M Buy
9,417
+1,702
+22% +$270K 0.18% 161
2020
Q4 		$1.17M Buy
7,715
+239
+3% +$34.2K 0.2% 139
2020
Q3 		$1.05M Buy
7,476
+163
+2% +$22.1K 0.2% 132
2020
Q2 		$1.02M Buy
7,313
+1,413
+24% +$180K 0.23% 125
2020
Q1 		$745K Buy
+5,900
New +$679K 0.2% 135
2019
Q2 		– Sell
-1,997
Closed -$213K – 317
2019
Q1 		$213K Sell
1,997
-568
-22% -$62.3K 0.06% 264
2018
Q4 		$281K Sell
2,565
-33
-1% -$3.5K 0.09% 230
2018
Q3 		$283K Buy
2,598
+330
+15% +$38.9K 0.22% 118
2018
Q2 		$249K Sell
2,268
-149
-6% -$15.9K 0.22% 121
2018
Q1 		$258K Buy
+2,417
New +$268K 0.24% 113

Other funds holding IBB

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
CA
Cumberland Advisors Sarasota, Florida $284M AUM 27.11% 1-Year Est. Return

PFG Advisors's IBB Position: Q2 2026 in Review

PFG Advisors reduced its iShares Biotechnology ETF (IBB) stake by 6.8% in Q2 2026, selling an estimated $33K and leaving 2,617 shares worth $498K. The position accounts for 0.03% of the portfolio, ranked #534.

PFG Advisors first reported a position in IBB in Q1 2018 and has held it in 28 quarters since. The position peaked at $1.49M in Q2 2021. 378 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • PFG Advisors held 2,617 shares of iShares Biotechnology ETF worth $498K as of Q2 2026.
  • PFG Advisors sold 192 iShares Biotechnology ETF shares in Q2 2026, an estimated $33K.
  • iShares Biotechnology ETF made up 0.03% of PFG Advisors's portfolio in Q2 2026, its #534 holding.
  • PFG Advisors first reported a position in iShares Biotechnology ETF in Q1 2018 and has held it in 28 quarters since.
  • PFG Advisors's iShares Biotechnology ETF position peaked at $1.49M in Q2 2021.
  • 378 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on PFG Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.